Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 240 of 240 entries
Sorted by: Best Match Show Resources per page
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone.

Therapeutic advances in urology

Zanardi E, Soldato D, Latocca MM, Cattrini C, Boccardo F.
PMID: 31217821
Ther Adv Urol. 2019 Jun 11;11:1756287219854908. doi: 10.1177/1756287219854908. eCollection 2019.

The recently published phase II prospective SWITCH trial evaluated whether patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate could benefit from a 'steroid switch' from prednisone to dexamethasone. A total of 26 patients, both chemonaïve (14...

Cite
Zanardi E, Soldato D, Latocca MM, et al. To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone. Ther Adv Urol. 2019;11:1756287219854908doi: 10.1177/1756287219854908.
Zanardi, E., Soldato, D., Latocca, M. M., Cattrini, C., & Boccardo, F. (2019). To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone. Therapeutic advances in urology, 111756287219854908. https://doi.org/10.1177/1756287219854908
Zanardi, Elisa, et al. "To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone." Therapeutic advances in urology vol. 11 (2019): 1756287219854908. doi: https://doi.org/10.1177/1756287219854908
Zanardi E, Soldato D, Latocca MM, Cattrini C, Boccardo F. To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone. Ther Adv Urol. 2019 Jun 11;11:1756287219854908. doi: 10.1177/1756287219854908. eCollection 2019. PMID: 31217821; PMCID: PMC6560791.
Copy Download .nbib Format: NLM
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients.

NPJ precision oncology

Puccini A, Seeber A, Xiu J, Goldberg RM, Soldato D, Grothey A, Shields AF, Salem ME, Battaglin F, Berger MD, El-Deiry WS, Tokunaga R, Naseem M, Zhang W, Arora SP, Khushman MM, Hall MJ, Philip PA, Marshall JL, Korn WM, Lenz HJ.
PMID: 34707195
NPJ Precis Oncol. 2021 Oct 27;5(1):95. doi: 10.1038/s41698-021-00230-y.

Lymph nodes (LNs) and distant metastases can arise from independent subclones of the primary tumor. Herein, we characterized the molecular landscape and the differences between LNs, distant metastases and primary colorectal cancers (CRCs). Samples were analyzed using next generation...

Cite
Puccini A, Seeber A, Xiu J, et al. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients. NPJ Precis Oncol. 2021;5(1):95doi: 10.1038/s41698-021-00230-y.
Puccini, A., Seeber, A., Xiu, J., Goldberg, R. M., Soldato, D., Grothey, A., Shields, A. F., Salem, M. E., Battaglin, F., Berger, M. D., El-Deiry, W. S., Tokunaga, R., Naseem, M., Zhang, W., Arora, S. P., Khushman, M. M., Hall, M. J., Philip, P. A., Marshall, J. L., Korn, W. M., & Lenz, H. J. (2021). Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients. NPJ precision oncology, 5(1), 95. https://doi.org/10.1038/s41698-021-00230-y
Puccini, Alberto, et al. "Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients." NPJ precision oncology vol. 5,1 (2021): 95. doi: https://doi.org/10.1038/s41698-021-00230-y
Puccini A, Seeber A, Xiu J, Goldberg RM, Soldato D, Grothey A, Shields AF, Salem ME, Battaglin F, Berger MD, El-Deiry WS, Tokunaga R, Naseem M, Zhang W, Arora SP, Khushman MM, Hall MJ, Philip PA, Marshall JL, Korn WM, Lenz HJ. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients. NPJ Precis Oncol. 2021 Oct 27;5(1):95. doi: 10.1038/s41698-021-00230-y. PMID: 34707195; PMCID: PMC8551277.
Copy Download .nbib Format: NLM
Investigating training-test data splitting strategies for automated segmentation and scoring of COVID-19 lung ultrasound images.

The Journal of the Acoustical Society of America

Roshankhah R, Karbalaeisadegh Y, Greer H, Mento F, Soldati G, Smargiassi A, Inchingolo R, Torri E, Perrone T, Aylward S, Demi L, Muller M.
PMID: 34972274
J Acoust Soc Am. 2021 Dec;150(6):4118. doi: 10.1121/10.0007272.

Ultrasound in point-of-care lung assessment is becoming increasingly relevant. This is further reinforced in the context of the COVID-19 pandemic, where rapid decisions on the lung state must be made for staging and monitoring purposes. The lung structural changes...

Cite
Roshankhah R, Karbalaeisadegh Y, Greer H, et al. Investigating training-test data splitting strategies for automated segmentation and scoring of COVID-19 lung ultrasound images. J Acoust Soc Am. 2021;150(6):4118doi: 10.1121/10.0007272.
Roshankhah, R., Karbalaeisadegh, Y., Greer, H., Mento, F., Soldati, G., Smargiassi, A., Inchingolo, R., Torri, E., Perrone, T., Aylward, S., Demi, L., & Muller, M. (2021). Investigating training-test data splitting strategies for automated segmentation and scoring of COVID-19 lung ultrasound images. The Journal of the Acoustical Society of America, 150(6), 4118. https://doi.org/10.1121/10.0007272
Roshankhah, Roshan, et al. "Investigating training-test data splitting strategies for automated segmentation and scoring of COVID-19 lung ultrasound images." The Journal of the Acoustical Society of America vol. 150,6 (2021): 4118. doi: https://doi.org/10.1121/10.0007272
Roshankhah R, Karbalaeisadegh Y, Greer H, Mento F, Soldati G, Smargiassi A, Inchingolo R, Torri E, Perrone T, Aylward S, Demi L, Muller M. Investigating training-test data splitting strategies for automated segmentation and scoring of COVID-19 lung ultrasound images. J Acoust Soc Am. 2021 Dec;150(6):4118. doi: 10.1121/10.0007272. PMID: 34972274.
Copy Download .nbib Format: NLM
Longitudinal Plantar Approach for Excision of Morton's Neuroma: Long-Term Results.

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons

Soldati F, Klaue K.
PMID: 34782249
J Foot Ankle Surg. 2021 Oct 22; doi: 10.1053/j.jfas.2021.10.010. Epub 2021 Oct 22.

Longitudinal plantar approaches are generally considered at risk for wound healing problems. Thus, we wanted to investigate long-term outcomes after a primary Morton's neuroma excision through a longitudinal plantar approach. A retrospective study of patients with primary neuroma excision...

Cite
Soldati F, Klaue K. Longitudinal Plantar Approach for Excision of Morton's Neuroma: Long-Term Results. J Foot Ankle Surg. 2021;doi: 10.1053/j.jfas.2021.10.010.
Soldati, F., & Klaue, K. (2021). Longitudinal Plantar Approach for Excision of Morton's Neuroma: Long-Term Results. The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons, . https://doi.org/10.1053/j.jfas.2021.10.010
Soldati, Francesco, and Klaue, Kaj. "Longitudinal Plantar Approach for Excision of Morton's Neuroma: Long-Term Results." The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons vol. (2021). doi: https://doi.org/10.1053/j.jfas.2021.10.010
Soldati F, Klaue K. Longitudinal Plantar Approach for Excision of Morton's Neuroma: Long-Term Results. J Foot Ankle Surg. 2021 Oct 22; doi: 10.1053/j.jfas.2021.10.010. Epub 2021 Oct 22. PMID: 34782249.
Copy Download .nbib Format: NLM
Development of a Deep-Learning Pipeline to Recognize and Characterize Macrophages in Colo-Rectal Liver Metastasis.

Cancers

Cancian P, Cortese N, Donadon M, Di Maio M, Soldani C, Marchesi F, Savevski V, Santambrogio MD, Cerina L, Laino ME, Torzilli G, Mantovani A, Terracciano L, Roncalli M, Di Tommaso L.
PMID: 34282750
Cancers (Basel). 2021 Jul 01;13(13). doi: 10.3390/cancers13133313.

Quantitative analysis of Tumor Microenvironment (TME) provides prognostic and predictive information in several human cancers but, with few exceptions, it is not performed in daily clinical practice since it is extremely time-consuming. We recently showed that the morphology of...

Cite
Cancian P, Cortese N, Donadon M, et al. Development of a Deep-Learning Pipeline to Recognize and Characterize Macrophages in Colo-Rectal Liver Metastasis. Cancers (Basel). 2021;13(13)doi: 10.3390/cancers13133313.
Cancian, P., Cortese, N., Donadon, M., Di Maio, M., Soldani, C., Marchesi, F., Savevski, V., Santambrogio, M. D., Cerina, L., Laino, M. E., Torzilli, G., Mantovani, A., Terracciano, L., Roncalli, M., & Di Tommaso, L. (2021). Development of a Deep-Learning Pipeline to Recognize and Characterize Macrophages in Colo-Rectal Liver Metastasis. Cancers, 13(13), . https://doi.org/10.3390/cancers13133313
Cancian, Pierandrea, et al. "Development of a Deep-Learning Pipeline to Recognize and Characterize Macrophages in Colo-Rectal Liver Metastasis." Cancers vol. 13,13 (2021). doi: https://doi.org/10.3390/cancers13133313
Cancian P, Cortese N, Donadon M, Di Maio M, Soldani C, Marchesi F, Savevski V, Santambrogio MD, Cerina L, Laino ME, Torzilli G, Mantovani A, Terracciano L, Roncalli M, Di Tommaso L. Development of a Deep-Learning Pipeline to Recognize and Characterize Macrophages in Colo-Rectal Liver Metastasis. Cancers (Basel). 2021 Jul 01;13(13). doi: 10.3390/cancers13133313. PMID: 34282750; PMCID: PMC8269198.
Copy Download .nbib Format: NLM
Modifying the Electron-Trapping Process at the BiVO.

ACS applied materials & interfaces

Usman E, Barzgar Vishlaghi M, Kahraman A, Solati N, Kaya S.
PMID: 34881879
ACS Appl Mater Interfaces. 2021 Dec 22;13(50):60602-60611. doi: 10.1021/acsami.1c16847. Epub 2021 Dec 09.

BiVO

Cite
Usman E, Barzgar Vishlaghi M, Kahraman A, et al. Modifying the Electron-Trapping Process at the BiVO. ACS Appl Mater Interfaces. 2021;13(50):60602-60611doi: 10.1021/acsami.1c16847.
Usman, E., Barzgar Vishlaghi, M., Kahraman, A., Solati, N., & Kaya, S. (2021). Modifying the Electron-Trapping Process at the BiVO. ACS applied materials & interfaces, 13(50), 60602-60611. https://doi.org/10.1021/acsami.1c16847
Usman, Emre, et al. "Modifying the Electron-Trapping Process at the BiVO." ACS applied materials & interfaces vol. 13,50 (2021): 60602-60611. doi: https://doi.org/10.1021/acsami.1c16847
Usman E, Barzgar Vishlaghi M, Kahraman A, Solati N, Kaya S. Modifying the Electron-Trapping Process at the BiVO. ACS Appl Mater Interfaces. 2021 Dec 22;13(50):60602-60611. doi: 10.1021/acsami.1c16847. Epub 2021 Dec 09. PMID: 34881879.
Copy Download .nbib Format: NLM
Geosystemics View of Earthquakes.

Entropy (Basel, Switzerland)

De Santis A, Abbattista C, Alfonsi L, Amoruso L, Campuzano SA, Carbone M, Cesaroni C, Cianchini G, De Franceschi G, De Santis A, Di Giovambattista R, Marchetti D, Martino L, Perrone L, Piscini A, Rainone ML, Soldani M, Spogli L, Santoro F.
PMID: 33267126
Entropy (Basel). 2019 Apr 18;21(4). doi: 10.3390/e21040412.

Earthquakes are the most energetic phenomena in the lithosphere: their study and comprehension are greatly worth doing because of the obvious importance for society. Geosystemics intends to study the Earth system as a whole, looking at the possible couplings...

Cite
De Santis A, Abbattista C, Alfonsi L, et al. Geosystemics View of Earthquakes. Entropy (Basel). 2019;21(4)doi: 10.3390/e21040412.
De Santis, A., Abbattista, C., Alfonsi, L., Amoruso, L., Campuzano, S. A., Carbone, M., Cesaroni, C., Cianchini, G., De Franceschi, G., De Santis, A., Di Giovambattista, R., Marchetti, D., Martino, L., Perrone, L., Piscini, A., Rainone, M. L., Soldani, M., Spogli, L., & Santoro, F. (2019). Geosystemics View of Earthquakes. Entropy (Basel, Switzerland), 21(4), . https://doi.org/10.3390/e21040412
De Santis, Angelo, et al. "Geosystemics View of Earthquakes." Entropy (Basel, Switzerland) vol. 21,4 (2019). doi: https://doi.org/10.3390/e21040412
De Santis A, Abbattista C, Alfonsi L, Amoruso L, Campuzano SA, Carbone M, Cesaroni C, Cianchini G, De Franceschi G, De Santis A, Di Giovambattista R, Marchetti D, Martino L, Perrone L, Piscini A, Rainone ML, Soldani M, Spogli L, Santoro F. Geosystemics View of Earthquakes. Entropy (Basel). 2019 Apr 18;21(4). doi: 10.3390/e21040412. PMID: 33267126; PMCID: PMC7514901.
Copy Download .nbib Format: NLM
Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI).

Frontiers in medicine

Solati Z, Surendran A, Edel A, Roznik M, Allen D, Ravandi A.
PMID: 34926484
Front Med (Lausanne). 2021 Dec 01;8:716944. doi: 10.3389/fmed.2021.716944. eCollection 2021.

No abstract available.

Cite
Solati Z, Surendran A, Edel A, et al. Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI). Front Med (Lausanne). 2021;8:716944doi: 10.3389/fmed.2021.716944.
Solati, Z., Surendran, A., Edel, A., Roznik, M., Allen, D., & Ravandi, A. (2021). Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI). Frontiers in medicine, 8716944. https://doi.org/10.3389/fmed.2021.716944
Solati, Zahra, et al. "Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI)." Frontiers in medicine vol. 8 (2021): 716944. doi: https://doi.org/10.3389/fmed.2021.716944
Solati Z, Surendran A, Edel A, Roznik M, Allen D, Ravandi A. Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI). Front Med (Lausanne). 2021 Dec 01;8:716944. doi: 10.3389/fmed.2021.716944. eCollection 2021. PMID: 34926484; PMCID: PMC8671696.
Copy Download .nbib Format: NLM
The Morbidity and Mortality Assessment Tool (MMAT): Design and Proof of Concept.

The Journal of surgical research

Soltani T, Tsoi K, Charles A, Csortan A, Lindsay J, Liu H, Loftus T, Ang D.
PMID: 34161841
J Surg Res. 2021 Nov;267:260-266. doi: 10.1016/j.jss.2021.04.025. Epub 2021 Jun 21.

BACKGROUND: Morbidity and Mortality Conference (MMC) is a traditional quality assessment tool among surgical residencies to evaluate complications within their care and to integrate and educate best practices. Unfortunately, it is difficult to validate and measure loop closure as...

Cite
Soltani T, Tsoi K, Charles A, et al. The Morbidity and Mortality Assessment Tool (MMAT): Design and Proof of Concept. J Surg Res. 2021;267:260-266doi: 10.1016/j.jss.2021.04.025.
Soltani, T., Tsoi, K., Charles, A., Csortan, A., Lindsay, J., Liu, H., Loftus, T., & Ang, D. (2021). The Morbidity and Mortality Assessment Tool (MMAT): Design and Proof of Concept. The Journal of surgical research, 267260-266. https://doi.org/10.1016/j.jss.2021.04.025
Soltani, Tandis, et al. "The Morbidity and Mortality Assessment Tool (MMAT): Design and Proof of Concept." The Journal of surgical research vol. 267 (2021): 260-266. doi: https://doi.org/10.1016/j.jss.2021.04.025
Soltani T, Tsoi K, Charles A, Csortan A, Lindsay J, Liu H, Loftus T, Ang D. The Morbidity and Mortality Assessment Tool (MMAT): Design and Proof of Concept. J Surg Res. 2021 Nov;267:260-266. doi: 10.1016/j.jss.2021.04.025. Epub 2021 Jun 21. PMID: 34161841.
Copy Download .nbib Format: NLM
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence.

Clinical breast cancer

Conte B, Soldato D, Razeti MG, Fregatti P, de Azambuja E, Schettini F, Prat A, Del Mastro L, Lambertini M.
PMID: 34750070
Clin Breast Cancer. 2022 Jan;22(1):78-87. doi: 10.1016/j.clbc.2021.10.001. Epub 2021 Oct 08.

Women with metastatic breast cancer remains a heterogeneous group of patients with different prognostic outcomes and therapeutic needs. Young women with de novo metastatic breast cancer (dnMBC) represent a peculiar population with respect to tumor biology, prognosis, clinical management...

Cite
Conte B, Soldato D, Razeti MG, et al. De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence. Clin Breast Cancer. 2021;22(1):78-87doi: 10.1016/j.clbc.2021.10.001.
Conte, B., Soldato, D., Razeti, M. G., Fregatti, P., de Azambuja, E., Schettini, F., Prat, A., Del Mastro, L., & Lambertini, M. (2022). De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence. Clinical breast cancer, 22(1), 78-87. https://doi.org/10.1016/j.clbc.2021.10.001
Conte, Benedetta, et al. "De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence." Clinical breast cancer vol. 22,1 (2022): 78-87. doi: https://doi.org/10.1016/j.clbc.2021.10.001
Conte B, Soldato D, Razeti MG, Fregatti P, de Azambuja E, Schettini F, Prat A, Del Mastro L, Lambertini M. De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence. Clin Breast Cancer. 2022 Jan;22(1):78-87. doi: 10.1016/j.clbc.2021.10.001. Epub 2021 Oct 08. PMID: 34750070.
Copy Download .nbib Format: NLM
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.

NPJ vaccines

Marsh GA, McAuley AJ, Au GG, Riddell S, Layton D, Singanallur NB, Layton R, Payne J, Durr PA, Bender H, Barr JA, Bingham J, Boyd V, Brown S, Bruce MP, Burkett K, Eastwood T, Edwards S, Gough T, Halpin K, Harper J, Holmes C, Horman WSJ, van Vuren PJ, Lowther S, Maynard K, McAuley KD, Neave MJ, Poole T, Rootes C, Rowe B, Soldani E, Stevens V, Stewart CR, Suen WW, Tachedjian M, Todd S, Trinidad L, Walter D, Watson N, Drew TW, Gilbert SC, Lambe T, Vasan SS.
PMID: 33972565
NPJ Vaccines. 2021 May 10;6(1):67. doi: 10.1038/s41541-021-00315-6.

Vaccines against SARS-CoV-2 are likely to be critical in the management of the ongoing pandemic. A number of candidates are in Phase III human clinical trials, including ChAdOx1 nCoV-19 (AZD1222), a replication-deficient chimpanzee adenovirus-vectored vaccine candidate. In preclinical trials,...

Cite
Marsh GA, McAuley AJ, Au GG, et al. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ Vaccines. 2021;6(1):67doi: 10.1038/s41541-021-00315-6.
Marsh, G. A., McAuley, A. J., Au, G. G., Riddell, S., Layton, D., Singanallur, N. B., Layton, R., Payne, J., Durr, P. A., Bender, H., Barr, J. A., Bingham, J., Boyd, V., Brown, S., Bruce, M. P., Burkett, K., Eastwood, T., Edwards, S., Gough, T., Halpin, K., Harper, J., Holmes, C., Horman, W. S. J., van Vuren, P. J., Lowther, S., Maynard, K., McAuley, K. D., Neave, M. J., Poole, T., Rootes, C., Rowe, B., Soldani, E., Stevens, V., Stewart, C. R., Suen, W. W., Tachedjian, M., Todd, S., Trinidad, L., Walter, D., Watson, N., Drew, T. W., Gilbert, S. C., Lambe, T., & Vasan, S. S. (2021). ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ vaccines, 6(1), 67. https://doi.org/10.1038/s41541-021-00315-6
Marsh, Glenn A, et al. "ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets." NPJ vaccines vol. 6,1 (2021): 67. doi: https://doi.org/10.1038/s41541-021-00315-6
Marsh GA, McAuley AJ, Au GG, Riddell S, Layton D, Singanallur NB, Layton R, Payne J, Durr PA, Bender H, Barr JA, Bingham J, Boyd V, Brown S, Bruce MP, Burkett K, Eastwood T, Edwards S, Gough T, Halpin K, Harper J, Holmes C, Horman WSJ, van Vuren PJ, Lowther S, Maynard K, McAuley KD, Neave MJ, Poole T, Rootes C, Rowe B, Soldani E, Stevens V, Stewart CR, Suen WW, Tachedjian M, Todd S, Trinidad L, Walter D, Watson N, Drew TW, Gilbert SC, Lambe T, Vasan SS. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ Vaccines. 2021 May 10;6(1):67. doi: 10.1038/s41541-021-00315-6. PMID: 33972565; PMCID: PMC8110954.
Copy Download .nbib Format: NLM
Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI).

Frontiers in medicine

Solati Z, Surendran A, Edel A, Roznik M, Allen D, Ravandi A.
PMID: 34926484
Front Med (Lausanne). 2021 Dec 01;8:716944. doi: 10.3389/fmed.2021.716944. eCollection 2021.

No abstract available.

Cite
Solati Z, Surendran A, Edel A, et al. Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI). Front Med (Lausanne). 2021;8:716944doi: 10.3389/fmed.2021.716944.
Solati, Z., Surendran, A., Edel, A., Roznik, M., Allen, D., & Ravandi, A. (2021). Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI). Frontiers in medicine, 8716944. https://doi.org/10.3389/fmed.2021.716944
Solati, Zahra, et al. "Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI)." Frontiers in medicine vol. 8 (2021): 716944. doi: https://doi.org/10.3389/fmed.2021.716944
Solati Z, Surendran A, Edel A, Roznik M, Allen D, Ravandi A. Increase in Plasma Oxidized Phosphatidylcholines (OxPCs) in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI). Front Med (Lausanne). 2021 Dec 01;8:716944. doi: 10.3389/fmed.2021.716944. eCollection 2021. PMID: 34926484; PMCID: PMC8671696.
Copy Download .nbib Format: NLM
Showing 229 to 240 of 240 entries